Joint Transition Committee Sample Clauses

Joint Transition Committee. 17.1 As soon as reasonably practical following the Completion Date, the parties will establish a joint steering committee (the “Joint Transition Committee” or “JTC”), comprised of two core representatives (one appointed by the Seller and one appointed by the Purchaser) and two individuals (one appointed by the Seller and one appointed by the Purchaser) responsible for managing the interactions between the Parties (“Alliance Managers”). Each party shall collectively have one (1) vote on the JTC. Each party shall provide the other party with written notice of its initial representatives on the JTC within ten (10) Business Days of the Completion Date. The parties may change the total number of core seats on the JTC by mutual agreement, provided that each party shall always hold the same number of seats on the JTC as the other party. Each party may substitute or replace any of its representatives on the JTC at any time for any reason upon written notice to the other party. *** Confidential Treatment Requested ***
Sample 1Sample 2
Joint Transition Committee. The Parties will establish a transition committee (the “Joint Transition Committee”) within thirty (30) days after the Effective Date to oversee, coordinate, and discuss the Services, Project Plan and the SOWs. The Joint Transition Committee will meet on a regularly scheduled basis (at such times to be agreed by the Joint Transition Committee) to: (a) oversee the generation of the Project Plan and (b) oversee and coordinate the Services set forth in the Project Plan. The Joint Transition Committee will be comprised of representatives of Qorvo and representatives of Zomedica. Each Party will notify the other of the appointment of its representatives to the Joint Transition Committee. Each Party may change its representatives to the Joint Transition Committee from time to time in its sole discretion, effective upon written notice to the other Party of such change. Such representatives will have appropriate credentials, experience, knowledge, and ongoing familiarity with the activities within the SOWs and Project Plan. Project Managers will be permitted to attend all Joint Transition Committee meetings, but will not be representatives of the Joint Transition Committee.
Sample 1
Joint Transition Committee. TASA and TMP shall promptly following the date hereof establish a joint transition committee, with representatives of senior management of both companies, to recommend steps to be carried out in combining the operations of the companies, to facilitate access to information and to consult and advise with respect to major activities of TASA pending the Acquisition; provided that such committee shall neither operate, nor make any agreement on behalf of, any of TASA or TMP prior to the Acquisition.
Sample 1
Joint Transition Committee. RKI and MMX shall promptly following the date hereof establish a joint transition committee, composed of Xxxxxxx Xxxx, Xxxxxxx Xxxx, Xxxx Xxx Xxxxx, Xxxxx Xxxxxx, Xxxxxx Xxxxx and Xxxxx Xxxxxxx, to recommend steps to be carried out in combining the operations of the companies, to facilitate access to information and to consult and advise with respect to major activities of RKI and MMX pending the Merger.
Sample 1
Joint Transition Committee. Within [***] Business Days after the Effective Date, the Parties shall establish a joint transition committee (“JTC”) to oversee the Kiniksa Transition Activities for, and for sharing information relating to the development of, the Licensed Antibodies and the Licensed Products under this Agreement.
Sample 1

Related to Joint Transition Committee

  • Transition Committee 8.1.0 A transition committee comprised of the employee representatives and the employer representatives, including the Crown, will be established by January 31, 2016 to address all matters that may arise in the creation of the Trust.

  • Joint Steering Committee [***] following the Effective Date [***], a joint steering committee (the “JSC”) will be established by the Parties to provide oversight and to facilitate information sharing between the Parties with respect to the activities under this Agreement.

  • Joint Commercialization Committee As of the Effective Date, the Parties have established a joint commercialization committee (the “Joint Commercialization Committee” or the “JCC”), composed of up to [ * ] representatives of each Party, to monitor and discuss the Commercialization of Products at the operational level. Each JCC representative shall have knowledge and expertise in the commercialization of products similar to Products. The JCC shall in particular:

  • Delegation; Committees The Trustees shall have the power, consistent with their continuing exclusive authority over the management of the Trust and the Trust Property, to delegate from time to time to such of their number or to officers, employees or agents of the Trust the doing of such things, including any matters set forth in this Declaration, and the execution of such instruments either in the name of the Trust or the names of the Trustees or otherwise as the Trustees may deem expedient. The Trustees may designate one or more committees which shall have all or such lesser portion of the authority of the entire Board of Trustees as the Trustees shall determine from time to time except to the extent action by the entire Board of Trustees or particular Trustees is required by the 1940 Act.

  • Steering Committee The Project Manager shall set up a Steering Committee for the Project, consisting of representatives from the Department, the Contractor, and any other key organisations whom the project will impact on, to be agreed between the parties. The function of the Steering Committee shall be to review the scope and direction of the Project against its aims and objectives, monitor progress and efficiency, and assess, manage and review expected impact and use of the findings from the Project. The Committee shall meet at times and dates agreed by the parties, or in the absence of agreement, specified by the Department. The Contractor’s representatives on the Steering Committee shall report their views on the progress of the Project to the Steering Committee in writing if requested by the Department. The Contractor’s representatives on the Steering Committee shall attend all meetings of the Steering Committee unless otherwise agreed by the Department.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Compensation Committee (A) The Compensation Committee shall be composed of not more than five (5) members who shall be selected by the Board of Directors from its own members who are not officers of the Company and who shall hold office during the pleasure of the Board.

  • Operating Committee the Consortium’s managing body, composed of representatives of the Manager and the Contractors, pursuant to Annex XI.

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!